Online Program

How much accessibility do patients in substance abuse treatment centers really have of pharmacological and behavioral treatments for smoking cessation?

Monday, November 4, 2013

Keriann M. Conway, MPH, Project Merits III, University of Georgia, Athens, GA
Jessica Legge Muilenburg, PhD, Department of Health Promotion and Behavior, University of Georgia, Athens, GA
Christina Proctor, PhD, Department of Health Promotion and Behavior, The University of Georgia, Athens, GA
Jessie Barnett, MPH, PhD, Department of Health Promotion and Behavior, University of Georgia, Athens, GA
Lillian Eby, PhD, Psychology, University of Georgia, Athens, GA
Many substance abuse treatment facilities do not necessarily make an effort to encourage smoking cessation, even if they have patients who are interested in quitting. The purpose of this study is to investigate the availability that patients have of pharmacological and behavioral treatments for smoking cessation. The study population of substance abuse counselors was derived from over 1,000 randomly-selected facilities using the SAMHSA database. A total of 1,054 counselors completed a web-based survey. We investigated what counselors actually provided to the last 10 patients who were addicted to nicotine. We found that behavioral therapies were much more accessible to patients than pharmacological therapies. Even though 45.1% of treatment centers reported accessibility of the nicotine patch, only 10.2% of the last 10 patients received this treatment. Similar trends are seen with other pharmacological therapies, including 29.9% having access to nicotine gum, with only 6.3% of their last 10 patients actually receiving this treatment. In terms of behavioral treatments, they were more accessible than pharmacological treatments. However, as with pharmacological therapies, they are not administered at a high percentage. This study will report on each of the therapies, both in accessibility and administration. From previous research, the best results for nicotine dependence are a combination of pharmacological and behavioral therapies. Given this research, it is important to include both therapies when treating nicotine addiction. Research in barriers to pharmacological therapies is the next step to treating nicotine addiction in drug and alcohol addicted patients.

Learning Areas:

Administer health education strategies, interventions and programs
Public health or related education
Public health or related research

Learning Objectives:
Discuss the accessibility of pharmacological and behavioral treatments for smoking cessation within substance abuse treatment centers.

Keyword(s): Smoking Cessation, Substance Abuse Treatment

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked as the grant coordinator on the NIDA-funded research study called Project Merits III since 2010. I have been involved in survey development, data collection, and the overall logistics and coordination involved in this research study investigating smoking cessation practices within substance abuse treatment facilities.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3416.0: Substance Abuse